Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043417
Filing Date
2021-08-11
Accepted
2021-08-11 16:01:31
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-10q_20210630.htm   iXBRL 10-Q 2467271
2 EX-3.1 alrn-ex31_544.htm EX-3.1 67664
3 EX-31.1 alrn-ex311_507.htm EX-31.1 16322
4 EX-31.2 alrn-ex312_508.htm EX-31.2 16180
5 EX-32.1 alrn-ex321_505.htm EX-32.1 7921
6 EX-32.2 alrn-ex322_506.htm EX-32.2 7021
  Complete submission text file 0001564590-21-043417.txt   7644842

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA alrn-20210630.xsd EX-101.SCH 40047
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alrn-20210630_cal.xml EX-101.CAL 38007
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alrn-20210630_def.xml EX-101.DEF 127037
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20210630_lab.xml EX-101.LAB 356315
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20210630_pre.xml EX-101.PRE 263191
12 EXTRACTED XBRL INSTANCE DOCUMENT alrn-10q_20210630_htm.xml XML 1337208
Mailing Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210
Business Address 285 SUMMER STREET UNIT 101 BOSTON MA 02210 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 211163311
SIC: 2834 Pharmaceutical Preparations